DocuSign, Inc. (NASDAQ:DOCU) CFO Blake Jeffrey Grayson Sells 16,111 Shares of Stock

DocuSign, Inc. (NASDAQ:DOCU) CFO Blake Jeffrey Grayson sold 16,111 shares of DocuSign stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $83.20, for a total value of $1,340,435.20. Following the sale, the chief financial officer now directly owns 93,960 shares in the company, valued at $7,817,472. The trade was a 14.64 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Blake Jeffrey Grayson also recently made the following trade(s):

• On Friday, February 14th, Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock. The stock was sold at an average price of $86.90, for a total value of $695,200.00.

DocuSign Stock Down 0.6 %

Shares of DOCU opened at $85.11 on Friday. The stock’s fifty day simple moving average is $87.58 and its 200-day simple moving average is $79.95. The firm has a market capitalization of $17.19 billion, a PE ratio of 17.55, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86.

DocuSign (NASDAQ:DOCU) last released its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. During the same period in the prior year, the company posted $0.76 EPS. The company’s revenue was up 9.0% compared to the same quarter last year. Analysts anticipate that DocuSign, Inc. will post 1.17 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on DOCU shares. Wells Fargo & Company increased their price objective on DocuSign from $70.00 to $73.00 and gave the stock an “underweight” rating in a research note on Friday, March 14th. Piper Sandler lifted their price target on shares of DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a report on Friday, December 6th. UBS Group reduced their price target on shares of DocuSign from $100.00 to $90.00 and set a “neutral” rating on the stock in a research report on Friday, March 14th. Citigroup raised their price objective on shares of DocuSign from $113.00 to $115.00 and gave the stock a “buy” rating in a report on Friday, March 14th. Finally, Bank of America reduced their target price on DocuSign from $112.00 to $98.00 and set a “neutral” rating on the stock in a report on Friday, March 14th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $95.00.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Itau Unibanco Holding S.A. acquired a new stake in shares of DocuSign during the third quarter worth $28,000. Kestra Investment Management LLC bought a new position in DocuSign during the fourth quarter worth about $30,000. Brooklyn Investment Group acquired a new position in shares of DocuSign during the 3rd quarter worth about $33,000. Modus Advisors LLC bought a new stake in shares of DocuSign in the 4th quarter valued at about $36,000. Finally, First Horizon Advisors Inc. increased its stake in shares of DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock valued at $36,000 after acquiring an additional 201 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.